Our goal is to reverse the human aging process and cure diseases linked to aging
Defytime Limited was established over 10 years ago to develop and bring to the world its technology to slow and ultimately cure aging in humans. Whilst this is a lofty goal, advancements in science are continuing to push the boundaries of knowledge and what is scientifically possible.
Defytime’s research and development activity sought to find and develop a replicable Telomerase Activation Compound (TAM) to cure TEDS (Telomerase Enzyme Deficiency Syndrome) which can then be used in its products and services. To date over USD$40 million has been spent on research and development pursuing this goal, led by Defytime director and shareholder, Dr Bill Andrews.